Table 2: Survival rates in HYPERO study. Adapted from [87].

Time-point HIPEC usednOS (m)2 years %5 years %

Overall14130.349.125.4
Frontline2641.757.033.3
Interval debulking1968.680.450.2
Consolidation1253.763.642.4
Recurrence8323.540.918.0

OS: overall survival.